SCHEMBL1469701

SCHEMBL1469701

CNCCCOc1ccc2sc3ccccc3c(=O)c2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.60
ALDH1A1 P00352 3/20 0.60
L3MBTL1 Q9Y468 3/20 0.60
NPC1 O15118 1/20 0.60
MAPT P10636 1/20 0.60
RAB9A P51151 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
HTR1B P28222 2/20 0.48
MAOA P21397 3/20 0.42
MAOB P27338 3/20 0.42
HTR1D P28221 1/20 0.42
RAD52 P43351 1/20 0.42
SLC6A4 P31645 1/20 0.42
HRH1 P35367 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
NSD2 O96028 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1797360 0.93 KDM4E (0.49) KDM4EALDH1A1L3MBTL1NPC1MAPT
SCHEMBL1793651 0.91 KDM4E (0.48) KDM4EALDH1A1L3MBTL1NPC1MAPT
SCHEMBL1795468 0.89 KDM4E (0.50) KDM4EALDH1A1L3MBTL1NPC1MAPT
SCHEMBL12848307 0.87 KDM4E (0.57) KDM4EALDH1A1L3MBTL1NPC1MAPT
SCHEMBL1799595 0.87 KDM4E (0.49) KDM4EALDH1A1L3MBTL1NPC1MAPT
SCHEMBL1798618 0.85 HTR1B (0.46) KDM4EALDH1A1L3MBTL1NPC1MAPT
SCHEMBL1795903 0.85 HTR1B (0.51) KDM4EALDH1A1L3MBTL1HTR1BHTR1D
SCHEMBL25998635 0.84 KDM4E (0.68) KDM4EALDH1A1L3MBTL1NPC1MAPT
SCHEMBL1469810 0.84 KDM4E (0.62) KDM4EALDH1A1L3MBTL1NPC1MAPT
SCHEMBL1505814 0.84 MAPT (0.67) KDM4EALDH1A1L3MBTL1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2130817-B1 Polymerizable Type II photoinitiators and curable compositions AGFA GRAPHICS NV (BE) 2016-01-06 EP disclosed
CN-102056892-B Multifunctional type II photoinitiators and curable compositions AGFA GRAPHICS NV 2015-07-22 CN disclosed
CN-102056890-B Polymerizable type II photoinitiators and curable compositions AGFA GRAPHICS NV 2015-02-04 CN disclosed
US-8389769-B2 Polymerizable type II photoinitiators and curable compositions AGFA GRAPHICS NV (BE) 2013-03-05 US disclosed
US-8362101-B2 Multifunctional type II photoinitiators and curable compositions AGFA GRAPHICS NV (BE) 2013-01-29 US disclosed
US-8362101-B2 Multifunctional type II photoinitiators and curable compositions AGFA GRAPHICS NV (BE) 2013-01-29 US disclosed
US-8362101-B2 Multifunctional type II photoinitiators and curable compositions AGFA GRAPHICS NV (BE) 2013-01-29 US disclosed
CN-102056892-A Multifunctional type II photoinitiators and curable compositions AGFA GRAPHICS NV 2011-05-11 CN disclosed
CN-102056890-A Polymerizable type II photoinitiators and curable compositions AGFA GRAPHICS NV 2011-05-11 CN disclosed
US-20110069130-A1 MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS AGFA GRAPHICS NV (BE) 2011-03-24 US disclosed
US-20110069130-A1 MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS AGFA GRAPHICS NV (BE) 2011-03-24 US disclosed
US-20110069130-A1 MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS AGFA GRAPHICS NV (BE) 2011-03-24 US disclosed
US-20110063388-A1 POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS AGFA GRAPHICS NV (BE) 2011-03-17 US disclosed
WO-2009147054-A1 MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS AGFA GRAPHICS NV (BE) 2009-12-10 WO disclosed
WO-2009147057-A1 POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS AGFA GRAPHICS NV (BE) 2009-12-10 WO disclosed
EP-2130818-A1 Multifunctional Type II photoinitiators and curable compositions AGFA Graphics NV (BE) 2009-12-09 EP disclosed
EP-2130817-A1 Polymerizable Type II photoinitiators and curable compositions AGFA Graphics NV (BE) 2009-12-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110069130-A1 MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS CRKL, CYTH2, CCNH KDM4E 1648/4885ALDH1A1 1579/4885L3MBTL1 1921/4885
US-20110063388-A1 POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS CCNH, CRKL, ERH KDM4E 1945/4885ALDH1A1 1584/4885L3MBTL1 1782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.